Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83

Gene Therapy

Volumn 15, Issue 9, 2008, Pages 652-659

  Yu, D H ^a   Hu, X D ^b   Cai, H ^a  

^a PEKING UNIVERSITY   (China)

^b Feed Research Institute   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; ISONIAZID; NITRIC OXIDE; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CANCER CHEMOTHERAPY; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; INTERFERON PRODUCTION; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; COLONY-FORMING UNITS ASSAY; COMBINED MODALITY THERAPY; FEMALE; GENE THERAPY; IMMUNOTHERAPY, ACTIVE; INTERFERON TYPE II; INTERLEUKIN-12; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY; VACCINES, DNA;

ANIMALIA; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 42149140542     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.13     Document Type: Article

References (29)

1. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19: 93-129.
2. Rook GA, Seah G, Ustianowski A. M. tuberculosis: Immunology and vaccination. Eur Respir J 2001; 17: 537-557.
3. Young D, Dye C. The development and impact of tuberculosis vaccines. Cell 2006; 124: 683-687.
4. Young DB, Duncan K. Prospects for new interventions in the treatment and prevention of mycobacterial disease. Annu Rev Microbiol 1995; 49: 641-673.
5. Bishai WR, Graham NM, Harrington S, Pope DS, Hooper N, Astemborski J et al. Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA 1998; 280: 1679-1684.
6. Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med 2003; 349: 1149-1156.
7. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178: 2243-2247.
8. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178: 2249-2254.
9. Lai WC, Pakes SP, Ren K, Lu YS, Bennett M. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. J Immunol 1997; 158: 2513-2516.
10. Lowrie DB, Tascon RE, Bonato VL, Lima VM, Faccioli LH, Stavropoulos E et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999, 400: 269-271.
11. Bonato VL, Goncalves ED, Scares EG, Santos Junior RR, Sartori A, Coelho-Castelo AA et al. Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: Activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury. Immunology 2004; 113: 130-138.
12. Ha SJ, Jeon BY, Kim SC, Kim DJ, Song MK, Sung YC et al. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Therapy 2003; 10: 1592-1599.
13. Ha SJ, Jeon BY, Youn JI, Kim SC, Cho SN, Sung YC. Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis. Gene Therapy 2005; 12: 634-638.
14. Silva CL, Bonato VL, Coelho-Castelo AA, De Souza AO, Santos SA, Lima KM et al. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Therapy 2005; 12: 281-287.
15. Zhu D, Jiang S, Luo X. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection. Vaccine 2005; 23: 4619-4624.
16. Krieg AM. Immune effects and mechanisms of action of CpG motifs. Vaccine 2000; 19: 618-622.
17. Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999; 20: 307-312.
18. Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Deck RR et al Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996; 2: 893-898.
19. Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 1999; 67: 1702-1707.
20. Bandera. A, Gori A, Catozzi L, Degli Esposti A, Marchetti G, Molteni C et al. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol 2001; 39: 2213-2218.
21. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341: 1174-1179.
22. Krieg AM, Love-Homan L, Yi AK, Harty JT. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 1998; 161: 2428-2434.
23. Cai H, Tian X, Hu XD, Li SX, Yu DH, Zhu YX. Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection. Vaccine 2005; 23: 3887-3895.
24. Cai H, Tian X, Hu XD, Zhuang YH, Zhu YX. Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis. DNA Cell Biol 2004; 23: 450-456.
25. Taylor JL, Turner OC, Basaraba RJ, Belisle JT, Huygen K, Orme IM. Pulmonary necrosis resulting from DNA vaccination against tuberculosis. Infect Immun 2003; 71: 2192-2198.
26. Skeiky YA, Ovendale PJ, Jen S, Alderson MR, Dillon DC, Smith S et al T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J Immunol 2000; 165: 7140-7149.
27. Seder RA. The role of IL12 in the regulation of Th1 and Th2 differentiation. Res Immunol 1995; 146: 473-476.
28. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997; 94: 5243-5248.
29. Cai H, Hu XD, Yu DH, Li SX, Tian X, Zhu YX. Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice. Vaccine 2005; 23: 4167-4174.